Additionally, PRCA in LGLL may result from autoantibody-dependent immune mechanisms involving immunoglobulins.27 The ability of MTX to reduce TNF-α levels and regulate the immune system may help explain the synergistic effect of the MTX-Thal combination in PRCA patients. The gene discussed is TNF; the disease is T-cell large granular lymphocyte leukemia.